IO BIOTECH INC. - COMMON STOCK

0,9400

13-февраля-25 16:45:00

15 мин. задержка

Акции

+0,0247

+2,70%

Сегодняшний диапазон

0,9005 - 0,9464

ISIN

N/A

Источник

NASDAQ

IO Biotech to Present at 44th Annual Cowen Health Care Conference

26 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial

21 дек 2023 08:30:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces 2023 Third Quarter Results

13 ноя 2023 08:12:16 Источник Nasdaq GlobeNewswire
IO Biotech Appoints Helen Collins, MD, to its Board of Directors

13 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire
IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma

10 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces Participation in Upcoming Investor Conferences

08 ноя 2023 16:30:00 Источник Nasdaq GlobeNewswire
IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

01 ноя 2023 08:30:00 Источник Nasdaq GlobeNewswire
Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Society for Medical Oncology (ESMO) Congress

23 окт 2023 01:00:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

03 окт 2023 16:30:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces New Data Related to its IO102-IO103 Therapeutic Cancer Vaccine Presented Today at the IASLC 2023 World Conference on Lung Cancer

12 сен 2023 08:05:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces Participation in Upcoming Investor Conferences

06 сен 2023 08:35:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces 2023 Second Quarter Results

11 авг 2023 08:30:00 Источник Nasdaq GlobeNewswire
IO Biotech Appoints Heidi Hunter to its Board of Directors

11 авг 2023 08:05:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces Abstract Accepted for Poster Presentation at ESMO Congress 2023

08 авг 2023 08:05:00 Источник Nasdaq GlobeNewswire
IO Biotech, Inc. Announces $75 Million Private Placement Financing

07 авг 2023 08:30:12 Источник Nasdaq GlobeNewswire
IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center

28 июл 2023 08:05:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces Abstract Accepted for Mini Oral Presentation at IASLC 2023 World Conference on Lung Cancer

25 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire
IO Biotech Strengthens Executive Management and US Presence with Appointment of Qasim Ahmad, MD, as Chief Medical Officer

18 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire
IO Biotech Announces Achievement of Significant Phase 3 Clinical Trial Recruitment Milestone

14 июн 2023 08:00:01 Источник Nasdaq GlobeNewswire
IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead

01 июн 2023 08:30:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.